Welcome to This Is MS!

     Modules
· Home
· Content
· Downloads
· Encyclopedia
· FAQ
· Feedback
· Forums
· Journal
· Private Messages
· Recommend Us
· Search
· Site_Map
· Stories Archive
· Submit News
· Surveys
· Top 10
· Topics
· Web Links
· Your Account

     Google
Google
Web
This is MS
These ads help pay for the upkeep of our site. They are automatically served by Google and are not affiliated with This is MS.

     Languages
Select Interface Language:


     Who''s Online
There are currently, 169 guest(s) and 49 member(s) that are online.

You are Anonymous user. You can register for free by clicking here

     Next Step

From the creators of This is MS comes Experience Project

EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at Experience Project.

Get started by sharing your Multiple Sclerosis story.


     Donations

To remain unbiased, This is MS does not accept corporate sponsorships.

Therefore, we must rely on our users to help support us. Please donate to our upkeep if you have the means. Thank you!


 Early Treatment Favoured for MS

Treatments for Multiple Sclerosisbromley writes "The pros and cons of early treatment have recently been debated in a medical journal. An editorial accompanying the debate comes down in favour of early treatment.

The essential arguments for the "Pro" camp include that: most who have MS will develop significant disability over time and that injury to nerve fibres begins early in the course of the disease.

The countering arguments for the "Cons" camp include: that if left untreated, MS often runs a ''''favourable'''' course and that the disease modifying drugs have not been proven to prevent long-term disability.

The NMSS'''' opinion ''''coincides'''' with the ''''Pro'''' camp.

Dr. Roach, a doctor at Wake Forest University who commented on the two approaches notes the necessity for finding specific evidence that some people do not need treatment...

Story continues... please click "read more"...

Continued

..."Without such evidence for individuals with MS, it will be difficult to know for sure whether it is ever safe to defer treatment," he concludes. "While it would be wonderful if we could avoid treating some patients with MS, until we can distinguish these individuals from the others, it is probably better to offer treatment to all patients except in the setting of a clinical trial."

Source

Many thanks to Bromley for writing and submitting this article."




 
     Login
Nickname

Password

Don't have an account yet? You can create one. As a registered user you have some advantages like theme manager, comments configuration and post comments with your name.

     Related Links
· More about Treatments for Multiple Sclerosis
· News by Administrator


Most read story about Treatments for Multiple Sclerosis:
Oral Therapy Laquinimod to Start Phase III Trials for RRMS


     Article Rating
Average Score: 4
Votes: 5


Please take a second and vote for this article:

Excellent
Very Good
Good
Regular
Bad


     Options

 Printer Friendly Printer Friendly






We encourage you to also visit our Multiple Sclerosis support community on Experience Project. Experience Project is a vast and powerful community where people connect anonymously through life experiences. It's made by the same people who built This is MS, on the premise that no single life experience-- like having MS-- defines a person. EP now covers over 5 million true stories about every possible life experience. Find and share yours!


Network Sites: Secret Confessions | Dream Meanings | Question and Answer | Song Meanings | Baby Name Meanings
Site Map

This site does not offer medical advice. All treatment decisions should always be made with the full consent of your physician.

 


All logos and trademarks in this site are property of their respective owners. The comments are property of their posters, quoted articles are © referenced source, all the rest © 2002-2010 by thisisMS.com.